Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What's the bid at?
"Young'uns"?.....Soon you'll be driving on the right side of road.
Not to nit pick, but it's UCSF.
With the Bryce Harper derby settled and opening day this week I'd say that's a fair analogy. Play Ball!
(Baseball references for those of you outside of North America)
In I believe November/December Dr. Liau received award from IU (Indiana Univesity). IU was a trial site and you confirmed their investigator was one of the 65 coauthors on the JTM article. Just an observation Jerry Jasinowski is an IU alumni.
Indeed.
In both of my experiences they worked. During the second go around the FDA approved them so users could get insurance reimbursement. I believe there is now a mechanical refrigeration device which I would think to be more comfortable as you could bring the temp down gradually and maintain on a consistent basis (more effective). The Penguin cold caps are chilled with dry ice and when they first go on the temp is around -25F (not pleasant for those donning) and kept on for 20-30 minutes and then repeat with freshly chilled cap over several hours
Wow. I've had the oportuinity to assist on two occasions women with their respective breast cancer treatment. My assist was with the application of Penguin cold caps which mitigate the hair loss side effect of chemo. Spending the hours with both woman and meeting others (as our cold cap endeavors were a bit of a curiosity) I found them to be a tight-nit group on doing and sharing their research on their respective breast cancer types/treatments. To that end more is needed for those diagnosed with triple negative. And this is not a group to be trifled with I hope Atezo proves to be a positive step forward.
New world. Good to see FDA is moving on this albeit not fast enough for some and at the same time too fast for others. I trust they'll get things dialed in as knowledge is gained. A long running data rich trial forgoing surrogates would add to this new and growing knowledge base.
Tis Hockey Night in Canada, but I'd prefer a "Blue" over Molson.
In this case 49% (almost half) is "not" good.
Indeed.
I assume no pun intended.
Indeed.
It is Pi day would be nice to get a slice of something......not that I need it (in more of a waistline sense) or expecting it.
Does the creamer make a hypergolic combination?
The runner-up for the IR job?
With his education and experience one would think he is jumping onboard with his eyes wide open.......and not unwittingly booking last minute passage on the Titanic.
And one would also think more meat and less reading of tea leaves is in order.
Her husband Evan ran for senate seat from Indiana in 2016 and lost. I suspect husband not getting the six year gig in D.C. not to mention direct connection to a senator and clout the seat wields came into play in her decision. Albeit (speculation) the decision may have been mutual between Mrs Bayh and NWBO.
Note: As Ex has pointed out the Bayh's are health care connected as well as politically (Indiana) connected.
Welcome to the 21st century.......it's still early (century not trial).
Does make one wonder about the possibilities (starting and effacacy) of combo trials.
Yes, the LLP is the winner in terms of vote total/percentage.
Perhaps FDA needs/wants to ride out an immunotherapy trial as far as possible to see how things actually shake out data wise. This old Nag of a long running trial could be a long shot data wise.....and otherwise.
Agreed. Longfellow has done Paul Revere's ride regarding hyper progression on this board.
Thanks Ike and everyone who attended the ASM.
I'd say adding heads is an interesting tidbit, thanks. It would also be interesting to find out whom at what level and where.
Monsanto = Bayer (Germans..... again)
Was not aware zombies consume same food stock as the living?
Les may not be in the loop and at minimum I would think he's familiar with the concept of plausible deniability.....not to cast aspersions
Hello. At least no "share holder alerts" for NWBO in quite a while.
Might need to go with single malt.
From memory I think the last two were on a Sunday.
I suspect in this instance buying a round or two would go a long way towards loosening lips.
Solid battery data.....solid enough for Elon to get a charge from?
FTF (Found To Follow-up)?
Because ICI's more or less off the shelf they'll always be an option for the fist line of defense. I think and suspect FDA needs to find out how far they can take the therapy......which might be what they are doing but would never cop (slang) to it.
As Longfellow has pointed out CI's as a monotherapy potentially have some issues. Perhaps CI's need some direction which could have an added benefit as you like point out the possibility reducing the CI dosage.
Agreed. Hence the list of questions is already too large it will need to be pared down.
(Thought the mental image comment was better than inquiring if a double bottom call should be made)
Thanks for the mental image.......need to erase that one.
Several thought CI combo was a bit of a reach (including me without stating so on this board). Still thinking there is more Trade Secret (in) Sauce than divulged so far.